ARCHIVES

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991

Moyniham Bill Will Direct HHS to Exempt Centers Recognized By NCI From Prospective Payment System

August 15, 1986

Medenica Granted Extension Of Privileges At Hilton Head Hospital

November 26, 1993

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997